Zobrazeno 1 - 10
of 488
pro vyhledávání: '"Eliav Barr"'
Autor:
Nancy Reau, Michael N. Robertson, Hwa‐Ping Feng, Luzelena Caro, Wendy W. Yeh, Bach‐Yen T. Nguyen, Janice Wahl, Eliav Barr, Peggy Hwang, Stephanie O. Klopfer
Publikováno v:
Hepatology Communications, Vol 1, Iss 8, Pp 757-764 (2017)
Concomitant proton pump inhibitor (PPI) use reduces plasma concentrations of certain nonstructural protein 5A inhibitors, which are key components of modern hepatitis C infection (HCV) treatments. These reduced concentrations may decrease efficacy, l
Externí odkaz:
https://doaj.org/article/4c7209c5aab146baa45be70dea5608b3
Autor:
Steven Flamm MD, Cheng-Yuan Peng MD, Oren Shibolet MD, Ronald Nahass MD, Peggy Hwang PhD, Eliav Barr MD, Michael N. Robertson MD, Barbara A. Haber MD
Publikováno v:
Gerontology and Geriatric Medicine, Vol 5 (2019)
Background: In elderly individuals aged ≥65 years with hepatitis C virus (HCV) infection, efficacious and safe HCV therapy is complicated by frequent comorbidities and concomitant medications. The aim of this analysis was to evaluate the efficacy a
Externí odkaz:
https://doaj.org/article/485010ee6c754ad7a4fce1c12c0cc871
Autor:
Richard M. Haupt, Eliav Barr, Alfred Saah, Teresa M. Hesley, Scott Vuocolo, Shuang Lu, Roger Maansson, Janine Bryan, Amha Tadesse, Christine Roberts, Frank J. Taddeo, Luisa L. Villa, Evan R. Myers, Nubia Muñoz, Slawomir Majewski, Elmar A. Joura, Joakim Dillner, F. Xavier Bosch, Marc Steben, Matti Lehtinen, Jorma Paavonen, Daron G. Ferris, Grace W.K. Tang, Sven-Eric Olsson, Sepp Leodolter, Suzanne M. Garland, Kevin A. Ault, Patricia García, Eng Hseon Tay, Laura A. Koutsky, Darron R. Brown, Gonzalo Perez, Cosette M. Wheeler, Mauricio Hernandez-Avila, Ole-Erik Iversen, Kristján Sigurdsson, Susanne K. Kjaer
Quadrivalent human papillomavirus (HPV) vaccine has been shown to provide protection from HPV 6/11/16/18–related cervical, vaginal, and vulvar disease through 3 years. We provide an update on the efficacy of the quadrivalent HPV vaccine against hig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8cbf736043abd5e445fae0fea6dcfd3c
https://doi.org/10.1158/1940-6207.c.6543580
https://doi.org/10.1158/1940-6207.c.6543580
Autor:
Richard M. Haupt, Eliav Barr, Alfred Saah, Teresa M. Hesley, Scott Vuocolo, Shuang Lu, Roger Maansson, Janine Bryan, Amha Tadesse, Christine Roberts, Frank J. Taddeo, Luisa L. Villa, Evan R. Myers, Nubia Muñoz, Slawomir Majewski, Elmar A. Joura, Joakim Dillner, F. Xavier Bosch, Marc Steben, Matti Lehtinen, Jorma Paavonen, Daron G. Ferris, Grace W.K. Tang, Sven-Eric Olsson, Sepp Leodolter, Suzanne M. Garland, Kevin A. Ault, Patricia García, Eng Hseon Tay, Laura A. Koutsky, Darron R. Brown, Gonzalo Perez, Cosette M. Wheeler, Mauricio Hernandez-Avila, Ole-Erik Iversen, Kristján Sigurdsson, Susanne K. Kjaer
PDF file - 284K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4be996bd795a851b1cff6ce8599ad0bb
https://doi.org/10.1158/1940-6207.22523068
https://doi.org/10.1158/1940-6207.22523068
Publikováno v:
Fair Disclosure Wire (Quarterly Earnings Reports). 11/30/2023.
Autor:
Jason Grebely, Gregory J. Dore, Frederick L. Altice, Brian Conway, Alain H. Litwin, Brianna L. Norton, Olav Dalgard, Edward J. Gane, Oren Shibolet, Ronald Nahass, Anne F. Luetkemeyer, Cheng-Yuan Peng, David Iser, Isaias Noel Gendrano, Michelle M. Kelly, Peggy Hwang, Ernest Asante-Appiah, Barbara A. Haber, Eliav Barr, Michael N. Robertson, Heather Platt
Publikováno v:
Annals of internal medicine. 175(9)
Hepatitis C virus (HCV) reinfection after successful treatment may reduce the benefits of cure among people who inject drugs.To evaluate the rate of HCV reinfection for 3 years after successful treatment among people receiving opioid agonist therapy
Publikováno v:
Fair Disclosure Wire (Quarterly Earnings Reports). 12/01/2022.
Autor:
Eliav Barr, Barbara Haber, Michael N. Robertson, Frederick L. Altice, Lawrence Serfaty, Ira M. Jacobson, Peggy Hwang, Jürgen K. Rockstroh
Publikováno v:
Journal of Viral Hepatitis. 26:329-336
European treatment guidelines for hepatitis C virus (HCV) infection recommend that people with genotype (GT) 1a infection and baseline viral load ≤800 000 IU/mL receive elbasvir/grazoprevir (EBR/GZR) for 12 weeks, and those with baseline viral load
Publikováno v:
Journal of Lipid Research, Vol 39, Iss 7, Pp 1372-1381 (1998)
To examine the association of apolipoprotein (apo) E with nascent hepatic lipoproteins we have prepared stable transfectants of the rat hepatoma cell line McA RH7777 expressing the human apoE3 cDNA. When the nascent lipoproteins secreted from control
Externí odkaz:
https://doaj.org/article/954d7dddb59e4fac9b11928fb5edb477
Autor:
Michael Robertson, John M Vierling, Velimir Luketic, George J Hanna, Luis A. Balart, Peggy Hwang, Reem Ghalib, Brian Pearlman, Bach-Yen Nguyen, Rohit Talwani, Natarajan Ravendhran, Philippe J Zamor, Eliav Barr
Publikováno v:
American Journal of Gastroenterology. 113:863-871
Although direct-acting antiviral regimens have dramatically improved the treatment of hepatitis C virus (HCV) infection, there is some evidence that black race may be an independent predictor of treatment failure. We report a retrospective analysis o